Rituximab-CHOP induced interstitial pneumonitis in patients with disseminated extranodal marginal zone B cell lymphoma

Citations

WEB OF SCIENCE

24
Citations

SCOPUS

25

초록

A 69-year-old male was diagnosed in February 2004 with stage IV extranodal marginal zone B cell lymphoma involving the mediastinal nodes, lung parenchyma and bone marrow with high LDH. Shortness of breath developed following the 5th course of Rituximab-CHOP chemotherapy (cyclophosphamide, Vincristine, Doxorubicin, Prednisolone). Bronchoscopy guided transbronchial lung biopsy revealed interstitial thickening and type II pneumocyte activation, compatible with interstitial pneumonitis. After treatment with prednisolone a complete resolution of the dyspnea was observed. The patient was well on routine follow-up at the outpatient clinic, with no progression of lymphoma or interstitial pneumonitis.

키워드

interstitial pneumonitis; rituximab; lymphoma; CHRONIC LYMPHOCYTIC-LEUKEMIA; TISSUE LYMPHOMA; LOW-LEVEL; T-CELLS; THERAPY; EXPRESSION; DISEASE; ANTIGEN
제목
Rituximab-CHOP induced interstitial pneumonitis in patients with disseminated extranodal marginal zone B cell lymphoma
저자
Kim, Kwang Min; Kim, Ho-Cheol; Jeon, Kyung-Nyeo; Kim, Hoon-Gu; Kang, Jung Hun; Hahm, Jong Ryeal; Lee, Gyeong-Won
DOI
10.3349/ymj.2008.49.1.155
발행일
2008-02
유형
Article
저널명
Yonsei Medical Journal
권
49
호
1
페이지
155 ~ 158